Big news: We are excited to now be a part of @abbottnews. Together, we will push earlier cancer detection and treatment guidance forward and help more people around the world achieve their best health. spr.ly/6019B6wnxS
English
Exact Sciences
3.8K posts
Exact Sciences
@ExactSciences
Exact Sciences is now Abbott. Together, we will transform the way the world approaches cancer. Follow @AbbottNews for future news and updates.
Madison, WI Katılım Mart 2010
785 Takip Edilen6.6K Takipçiler
We’re looking forward to sharing new data at the 2026 American Association for Cancer Research (AACR) Annual Meeting in April. Learn more: spr.ly/6014B6raR8
English
Exact Sciences retweetledi
And now, Kevin Conroy, chair and CEO of Exact Sciences (@ExactSciences) joins @heatherscope to continue the conversation on cancer screening and prevention.
English
Millions of adults are overdue for colorectal cancer screening.
In this new @Forbes feature, Dr. Paul Limburg discusses screening barriers — from workforce shortages to access challenges — and what it will take to close the gap.
spr.ly/6019hvrBD
English
Today, we announced our fourth quarter and full year 2025 earnings results. Read more here: spr.ly/6013hpeCf
English
Exact Sciences retweetledi
In honor of World Cancer Day, Badger student-athletes and @ExactSciences are sharing powerful personal stories to spotlight the impact of cancer and the life-changing power of prevention. Together, we’re raising awareness and taking action.
English
We applaud Congress on the passage of the #MCEDAct. This landmark legislation establishes a Medicare coverage pathway for MCED tests, such as the Cancerguard® test. Read more: spr.ly/6015hHxRF
English
BREAKING: Our Oncotype DX Breast Recurrence Score® test has surpassed 2 million patients served worldwide, potentially sparing an estimated 1.6 million from unnecessary chemotherapy. Read about this impactful milestone: spr.ly/6014hH928 #OncotypeDX2Million
English
Bipartisan, bicameral support for the #MCEDAct reflects a shared commitment to improving early cancer detection. We’re proud to stand with the advocacy community in supporting progress this January.
Prevent Cancer Foundation@preventcancer
More than 550 cancer advocacy organizations nationwide have highlighted the importance of the #MCEDAct. With tremendous bipartisan, bicameral backing, this legislation is ready to pass this January. @LeaderJohnThune @SenSchumer @SpeakerJohnson @RepJeffries Let’s get this done.
English
Health insurers are sending use-at-home colon cancer screening kits directly to eligible adults – and the strategy is helping to reach those who face barriers to screening. Read more: spr.ly/6011Cu3QW
@katiecouric
English
Clinical study results presented at #SABCS25 demonstrate the Oncodetect® test’s powerful prognostic performance in early triple-negative breast cancer. Read more: spr.ly/6012CDhEQ
English
Exact Sciences retweetledi
Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
Guest editorial by @ExactSciences' Paul J. Limburg
cancerletter.com/trials-and-tri…
English
When you say ‘Wisconsin’, you’ve said it all! Congratulations to the @UWBadgers for winning the @AbbottNews and Big Ten blood donation competition. ❤️🦡
Abbott@AbbottNews
This season, the @bigten went BIG. All 18 schools went head-to-head in the ultimate blood donation competition, saving nearly 250,000 lives, but @UWMadison is taking home the W. Congratulations to the Badgers who helped save more than 45,000 lives. ❤️🩸
English
We’re sharing data at #SABCS25 showcasing our commitment to advancing breast cancer care and providing actionable insights for patients and their health care providers: spr.ly/60107Wij8
English
Incredible momentum for the #MCEDAct! We’re proud to support efforts that expand access to innovative cancer technologies so that more people benefit from earlier detection and better outcomes.
American Cancer Society Cancer Action Network@ACSCAN
The #MCEDAct hit 400 cosponsors today! As the most-supported bill in Congress, there's overwhelming bipartisan support to get this important legislation over the finish line. 💪 If passed, it could help innovative cancer #EarlyDetection tests reach more people who need them.
English
@Winteryweather Thank you for reaching out. We will escalate this feedback to the appropriate team. Our Customer Care team can help answer questions about individual orders and document additional feedback at 1-844-870-8870.
English
@ExactSciences Wife got this in the mail, called as we are self pay/no insurance and they didnt give the price and then we got a bill for $681 in the mail after the test was done. This is egregiously expensive for a sample test.
English
To help address barriers to screening and improve gaps in preventive care, we’re helping health plans reach patients in the most direct way possible: by proactively sending Cologuard® kits to those who are eligible and overdue for CRC screening. 🔗 spr.ly/6017AAvWW
English
Exciting news! With the Hart-Scott-Rodino Act waiting period complete, our license agreement with Freenome moves forward.
Together, we’re working toward a future where even more people can detect cancer earlier. Read more: spr.ly/60117TRbF
English
Results from our landmark ALTUS study demonstrate superior early detection of liver cancer with the Oncoguard® Liver blood test. Read more: spr.ly/60157PSxV
English
Today, we announced our third quarter 2025 earnings results. For more information, see our press release here: spr.ly/60107KcH0
English
Two breast cancer survivors, one who received chemotherapy and the other who didn’t, explain why they both know they made the right choice. Read here: spr.ly/60197DYA5 via Katie Couric Media @katiecouric
English